BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23084855)

  • 1. Acellular pertussis vaccines in China.
    Wang L; Lei D; Zhang S
    Vaccine; 2012 Nov; 30(50):7174-8. PubMed ID: 23084855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines.
    Gaines-Das R; Horiuchi Y; Zhang SM; Newland P; Kim Y; Corbel M; Xing D
    Vaccine; 2009 Nov; 27(49):6824-32. PubMed ID: 19765397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do we need a new vaccine to control the re-emergence of pertussis?
    Mills KH; Ross PJ; Allen AC; Wilk MM
    Trends Microbiol; 2014 Feb; 22(2):49-52. PubMed ID: 24485284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acellular pertussis vaccines in Japan: past, present and future.
    Watanabe M; Nagai M
    Expert Rev Vaccines; 2005 Apr; 4(2):173-84. PubMed ID: 15889991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Licensed pertussis vaccines in the United States. History and current state.
    Klein NP
    Hum Vaccin Immunother; 2014; 10(9):2684-90. PubMed ID: 25483496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology.
    Sheridan SL; Frith K; Snelling TL; Grimwood K; McIntyre PB; Lambert SB
    Expert Rev Vaccines; 2014 Sep; 13(9):1081-106. PubMed ID: 25093268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced risk of pertussis in whole-cell compared to acellular vaccine recipients is not confounded by age or receipt of booster-doses.
    Sheridan SL; Ware RS; Grimwood K; Lambert SB
    Vaccine; 2015 Sep; 33(39):5027-30. PubMed ID: 26297874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Underestimating the safety benefits of a new vaccine: the impact of acellular pertussis vaccine versus whole-cell pertussis vaccine on health services utilization.
    Hawken S; Manuel DG; Deeks SL; Kwong JC; Crowcroft NS; Wilson K
    Am J Epidemiol; 2012 Dec; 176(11):1035-42. PubMed ID: 23118103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acellular pertussis preschool booster vaccination.
    Hviid A
    Pediatr Infect Dis J; 2008 Jun; 27(6):573-4. PubMed ID: 18458647
    [No Abstract]   [Full Text] [Related]  

  • 10. Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort.
    Witt MA; Arias L; Katz PH; Truong ET; Witt DJ
    Clin Infect Dis; 2013 May; 56(9):1248-54. PubMed ID: 23487373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WHO Working Group meeting on standardization of acellular pertussis vaccines: Potency assay Beijing, China, 7-9 November 2007.
    Knezevic I; Baca-Estrada M; Xing DK; Lei D;
    Vaccine; 2008 Jul; 26(32):3960-8. PubMed ID: 18514369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What's wrong with acellular pertussis vaccines?
    Wiedermann BL
    Clin Ther; 2013 Feb; 35(2):115-8. PubMed ID: 23375491
    [No Abstract]   [Full Text] [Related]  

  • 13. New pertussis vaccination approaches: en route to protect newborns?
    Locht C; Mielcarek N
    FEMS Immunol Med Microbiol; 2012 Nov; 66(2):121-33. PubMed ID: 22574832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WHO working group on standardisation and control of acellular pertussis vaccines--report of a meeting held on 16-17 March 2006, St. Albans, United Kingdom.
    Xing DK; Corbel MJ; Dobbelaer R; Knezevic I
    Vaccine; 2007 Apr; 25(15):2749-57. PubMed ID: 17368348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of immunisation strategies for pertussis vaccines in Jinan, China - an interrupted time-series study.
    Liu TC; Zhang J; Liu SQ; Yin AT; Ruan SM
    Epidemiol Infect; 2020 Feb; 148():e26. PubMed ID: 32046804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting future trends in the burden of pertussis in the 21st century: implications for infant pertussis and the success of maternal immunization.
    van den Biggelaar AH; Poolman JT
    Expert Rev Vaccines; 2016; 15(1):69-80. PubMed ID: 26559122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whooping cough, twenty years from acellular vaccines introduction.
    Greco D; Esposito S; Tozzi A; Pandolfi E; Icardi G; Giammanco A
    Ann Ig; 2015; 27(2):415-31. PubMed ID: 26051141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-cell but not acellular pertussis vaccines induce convulsive activity in mice: evidence of a role for toxin-induced interleukin-1beta in a new murine model for analysis of neuronal side effects of vaccination.
    Donnelly S; Loscher CE; Lynch MA; Mills KH
    Infect Immun; 2001 Jul; 69(7):4217-23. PubMed ID: 11401957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak.
    Witt MA; Katz PH; Witt DJ
    Clin Infect Dis; 2012 Jun; 54(12):1730-5. PubMed ID: 22423127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine and antibody profiles in 1-year-old children vaccinated with either acellular or whole-cell pertussis vaccine during infancy.
    Dirix V; Verscheure V; Goetghebuer T; Hainaut M; Debrie AS; Locht C; Mascart F
    Vaccine; 2009 Oct; 27(43):6042-7. PubMed ID: 19665604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.